MET Kinase Inhibitor Patent US12595245B2 Granted
Summary
The USPTO granted patent US12595245B2 to Celyn Therapeutics, Inc. covering MET receptor tyrosine kinase inhibitor compounds, pharmaceutical compositions, and methods of use for treating disease. The patent contains 18 claims and is classified under CPC codes C07D 401/12, C07D 215/22, C07D 405/14, and C07D 471/04. This grant establishes enforceable intellectual property rights for the disclosed MET kinase inhibitors.
What changed
USPTO granted patent US12595245B2 to Celyn Therapeutics, Inc., awarding exclusive intellectual property rights for MET receptor tyrosine kinase inhibitor compounds, pharmaceutical compositions, and associated treatment methods. The patent issues from Application No. 18341503, filed June 26, 2023, with 18 claims covering the disclosed chemical compounds and their therapeutic applications.
Pharmaceutical manufacturers and biotechnology companies engaged in MET-targeted oncology or precision medicine development should monitor this patent for freedom-to-operate considerations and potential licensing opportunities. The grant reinforces the commercial viability of the assignees' kinase inhibitor pipeline and provides enforceable IP protection in the competitive MET inhibitor therapeutic space.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Inhibitors of MET kinase
Grant US12595245B2 Kind: B2 Apr 07, 2026
Assignee
CELYN THERAPEUTICS, INC.
Inventors
Xiaohu S. Ouyang, Toufike Kanouni, John S. Tyhonas, Jason M. Cox, Robert S. Kania
Abstract
Provided herein are inhibitors of MET receptor tyrosine kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MET kinase inhibitory compounds for the treatment of disease.
CPC Classifications
C07D 401/12 C07D 215/22 C07D 405/14 C07D 471/04
Filing Date
2023-06-26
Application No.
18341503
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.